These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24093878)

  • 1. Severe hyponatremia following radioactive iodine therapy in patients with differentiated thyroid cancer.
    Kim SK; Yun GY; Kim KH; Park SK; Choi HY; Ha SK; Park HC
    Thyroid; 2014 Apr; 24(4):773-7. PubMed ID: 24093878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for developing hyponatremia in thyroid cancer patients undergoing radioactive iodine therapy.
    Lee JE; Kim SK; Han KH; Cho MO; Yun GY; Kim KH; Choi HY; Ryu YH; Ha SK; Park HC
    PLoS One; 2014; 9(8):e106840. PubMed ID: 25170831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation for radioactive iodine therapy is not a risk factor for the development of hyponatremia in thyroid cancer patients.
    Kim J; Cho SG; Kang SR; Kwon SY; Cho DH; Cho JS; Song HC
    Medicine (Baltimore); 2017 Feb; 96(5):e6004. PubMed ID: 28151897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma.
    Shakir MK; Krook LS; Schraml FV; Hays JH; Clyde PW
    Thyroid; 2008 Jul; 18(7):787-92. PubMed ID: 18631009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothyroidism and hyponatremia: data from a series of patients with iatrogenic acute hypothyroidism undergoing radioactive iodine therapy after total thyroidectomy for thyroid cancer.
    Vannucci L; Parenti G; Simontacchi G; Rastrelli G; Giuliani C; Ognibene A; Peri A
    J Endocrinol Invest; 2017 Jan; 40(1):49-54. PubMed ID: 27507082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Hyponatremia in Hypothyroid Patients during Radioactive ¹³¹I Ablation for Differentiated Thyroid Cancer: Single Institution Experience.
    Dayrit JC; Cunanan EC; Kho SA
    Endocrinol Metab (Seoul); 2016 Sep; 31(3):410-415. PubMed ID: 27546873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hyponatremia in association with I(131) therapy in a patient with metastatic thyroid cancer.
    Nozu T; Yoshida Y; Ohira M; Okumura T
    Intern Med; 2011; 50(19):2169-74. PubMed ID: 21963736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.
    Tuttle RM; Leboeuf R; Robbins RJ; Qualey R; Pentlow K; Larson SM; Chan CY
    J Nucl Med; 2006 Oct; 47(10):1587-91. PubMed ID: 17015892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperkalemia develops in some thyroidectomized patients undergoing thyroid hormone withdrawal in preparation for radioactive iodine ablation for thyroid carcinoma.
    Horie I; Ando T; Imaizumi M; Usa T; Kawakami A
    Endocr Pract; 2015 May; 21(5):488-94. PubMed ID: 25667379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Radioactive Iodine Therapy on Ovarian Function and Fertility in Female Thyroid Cancer Patients: A Systematic Review and Meta-Analysis.
    Piek MW; Postma EL; van Leeuwaarde R; de Boer JP; Bos AME; Lok C; Stokkel M; Filipe MD; van der Ploeg IMC
    Thyroid; 2021 Apr; 31(4):658-668. PubMed ID: 33012254
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid rise in serum thyrotropin concentrations after thyroidectomy or withdrawal of suppressive thyroxine therapy in preparation for radioactive iodine administration to patients with differentiated thyroid cancer.
    Serhal DI; Nasrallah MP; Arafah BM
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3285-9. PubMed ID: 15240604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary and lacrimal gland dysfunction after remnant ablation with radioactive iodine in patients with differentiated thyroid carcinoma prepared with recombinant human thyrotropin.
    Rosario PW; Calsolari MR
    Thyroid; 2013 May; 23(5):617-9. PubMed ID: 23136908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cohort study on radioactive iodine-induced hypothyroidism: implications for Graves' ophthalmopathy and optimal timing for thyroid hormone assessment.
    Stan MN; Durski JM; Brito JP; Bhagra S; Thapa P; Bahn RS
    Thyroid; 2013 May; 23(5):620-5. PubMed ID: 23205939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioactive iodine therapy.
    Lee SL
    Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):420-8. PubMed ID: 22914564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low iodine diet in differentiated thyroid cancer: a review.
    Li JH; He ZH; Bansal V; Hennessey JV
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):3-12. PubMed ID: 26118628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild decreases in white blood cell and platelet counts are present one year after radioactive iodine remnant ablation.
    Molinaro E; Leboeuf R; Shue B; Martorella AJ; Fleisher M; Larson S; Tuttle RM
    Thyroid; 2009 Oct; 19(10):1035-41. PubMed ID: 19772430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current controversies in the initial post-surgical radioactive iodine therapy for thyroid cancer: a narrative review.
    Blumhardt R; Wolin EA; Phillips WT; Salman UA; Walker RC; Stack BC; Metter D
    Endocr Relat Cancer; 2014; 21(6):R473-84. PubMed ID: 25277792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thyroid hormone withdrawal on metabolic and cardiovascular parameters during radioactive iodine therapy in differentiated thyroid cancer.
    An JH; Song KH; Kim DL; Kim SK
    J Int Med Res; 2017 Feb; 45(1):38-50. PubMed ID: 27856930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation.
    Grewal RK; Larson SM; Pentlow CE; Pentlow KS; Gonen M; Qualey R; Natbony L; Tuttle RM
    J Nucl Med; 2009 Oct; 50(10):1605-10. PubMed ID: 19759114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation Dose-rate Reduction Pattern in Well-differentiated Thyroid Cancer Treated with I-131.
    Khan SA; Khan MS; Arif M; Durr-e-Sabih ; Rahim MK; Ahmad I
    J Coll Physicians Surg Pak; 2015 Jul; 25(7):510-3. PubMed ID: 26208555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.